Spermidine/spermine N1-acetyltransferase transient overexpression restores sensitivity of resistant human ovarian cancer cells to N1N12-bis(ethyl)spermine and to cisplatin

Carcinogenesis

Volumn 26, Issue 10, 2005, Pages 1677-1686

  Marverti, Gaetano ^c   Monti, Maria Giuseppina ^c   Pegg, Anthony E ^a   McCloskey, Diane E ^a   Bettuzzi, Saverio ^b   Ligabue, Alessio ^b   Caporali, Andrea ^b   D'Arca, Domenico ^c   Moruzzi, Maria Stella ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CISPLATIN; DNA; N1,N12 DIETHYLSPERMINE; SPERMIDINE; SPERMINE; ANTINEOPLASTIC AGENT; DIAMINE ACETYLTRANSFERASE; DIAMINE N-ACETYLTRANSFERASE; DRUG DERIVATIVE; N(1), N(12) DIETHYLSPERMINE; N(1), N(12)-DIETHYLSPERMINE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL GROWTH; CELL SURVIVAL; COMET ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME REPRESSION; EXPRESSION VECTOR; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; CYSTADENOCARCINOMA; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ACETYLTRANSFERASES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; CYSTADENOCARCINOMA; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; SPERMINE; TRANSFECTION;

EID: 27144468971     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi129     Document Type: Article

References (49)

1. Kayev, B., Lewis, C.R., Paul, J., Duncan, I.D., Gordon, H.K., Ktchener, H.C., Cruichshank, D.J., Atkinson, R.J., Soukop, M. and Rankin, E.M. (1992) Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer. Lancet, 340, 329-333.
2. Johnson, S.W., Ozols, R.F. and Hamilton, T.C. (1993) Mechanisms of drug resistance in ovarian cancer. Cancer, 71, 644-649.
3. Andrews, P.A. and Albright, K.D. (1992) Mitochondrial detects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res., 52. 1895-1901.
4. Johnson, S.W., Laub, P.B., Beesleyl, J.S., Ozols, R.F. and Hamilton, F.C. (1997) Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res., 57, 850-856.
5. 12-bis(ethyl spermine effect on growth of cis-diamminedichloroplatinum(II)-sensitive and -resistant human ovarian-carcinoma cell lines. Int. J. Cancer, 78, 33-40.
6. 12-bis(ethyl)spermine involves transcriptional and post -transcriptional regulation. Eur. J. Cancer, 37, 281-289.
7. 1-acetyltransferase expression. Int. J. Biochem. Cell Biol., 36, 123-137.
8. 1-acetyltransferase superinduced in response to treatment with antitumour polyamine analogues. Cancer Res., 54, 3955-3958.
9. Vujcic, S., Diegelman, P., Bacchi, C.J., Kramer, D.L. and Porter, C.W. (2002) Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin. Biochem. J., 367, 665-675.
10. O Devereux, W., Wang, Y., Stuart, T.M. et al. (2003) Induction of the PAOh1/ SMO polyamine oxidase by polyamine analogues in human lung carcinoma cells. Cancer Chemother. Pharmacol., 52, 383-390.
11. Pegg, A.E. (1988) Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res., 48, 759-774.
12. Nairn, L.M., Lindsay, G.S., Woster, P.M. and Wallace, H.M. (2000) Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cells. J, Cell. Physiol., 182, 209-213.
13. Marton, L.J. and Pegg, A.E. (1995) Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol., 35, 55-91.
14. 12-bis(ethyl)spermine in human cell lines representing the major forms of lung cancer. Cancer Res., 52, 5359-5363,
15. 1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res., 51, 3715-3720.
16. 1-acetyltransferase without cytotoxicity by the growth-supporting polyamine analogue 1.12-dimethylspermine. J. Cell. Physiol., 165, 71-77.
17. Ha, H.C., Woster, P.M., Yager. J.D. and Casero, R.A. Jr. (1997) The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl Acad. Sci. USA, 94, 11557-11562.
18. Ha, H.C., Woster, P.M. and Casero, R.A. Jr. (1998) Unsymmetrically substituted polyamine analogue induces caspase-independent programmed cell death in bcl-2-overexpressing cells. Cancer Res., 58, 2711-2714.
19. McCloskey, D.E., Casero, R.A. Jr., Woster, P.M. and Davidson, N.E. (1995) Induction of programmed cell death in human breast cancer cells by an unsymmetrically substituted polyamine analogue. Cancer Res., 55, 3233-3236.
20. 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J. Biol. Chem., 275, 38319-38328.
21. Kee, K., Vujcic, S., Merali. S., Kisiel, N., Powell, C.T., Kramer, D.L. and Porter. C.M. (2004) Metabolism and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells. J. Biol. Chem., 279, 27050-27058.
22. 1-acetyltransferase activity as a mechanism of cellular resistance to bis(ethyl)polyamine analogues. J. Biol. Chem., 275, 28708-28714.
23. Scorcioni, F., Corti, A., Davalli, P., Astancolle, S. and Bettuzzi, S. (2001) Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression. Biochem, J., 354. 217-223.
24. 11-bis(ethyl)norspermine with cis-diamminedichloroplatinum(II) against murine neoplasm cell lines in vitro and in vivo. Cancer Lett., 99, 99-107.
25. Hahm, H.A., Dunn, V.R., Butash, K.A., Deveraux, W.L., Woster, P.W., Casero, R.A. Jr. and Davidson, N.E. (2001) Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cell lines. Clin. Cancer Res., 7, 391-399.
26. Bettuzzi. S., Davalli, P., Astancolle, S., Pinna, C., Roncaglia, R., Boraldi, F., Tiozzo, R., Sharrad. M. and Corti, A. (1999) Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts. FEBS Lett., 446, 18-22.
27. 1-acetyltransferase stably expressed in Chinese hamster ovary cells. J. Biol. Chem., 274, 6175-6182.
28. 1-acetyltransferase in human large cell lung carcinoma. Biochem. J., 270, 615-620.
29. 1-acetyltransferase using specific antiserum. J. Biol. Chem., 259, 12364-12367.
30. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
31. Kueng, W., Siber, E. and Eppenberger, U. (1989) Quantification of cells cultured on 96-well plates. Anal. Biochem., 182, 16-19.
32. Seiler, N.B., Knodgen, B. and Eisenbess, F. (1978) Determination of di- and polyamines by high-performance liquid-chromatographic separation of their 5-dimethylaminonaphthalene-1-sulfonyl derivatives. J. Chromatogr., 145, 29-39.
33. Johnson, M.K., and Loo, G. (2000) Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. Mutat. Res., 459, 29-39.
34. Buchberger, B., Fernholz, E., Bantle, M., Weigert, E., Borowsky, H., v.d. Eliz, H. and Hinzpeter, M. (1996) Dosper liposomal transfection reagent: A reagent with unique transfection properties. Biochemica, 2, 7-10.
35. Basu, H.S., Pellarin, M., Feuerstein, B.G. and Marton, J.J. (1996) The ability of polyaminne analogues to induce Z-DNA structure in synthetic polynucleotides in vitro inversely correlates with their effects on cytotoxicity of cis-diamminedichloroplatinum(II) (CDDP) in human brain tumor cell lines. Anticancer Res.. 16, 39-47.
36. Hartmann, A. and Speit, G. (1995) Genotoxic effects of chemicals in the single cell gel (SCG) test with human blood cells in relation to the induction of sister-chromatid exchanges (SCE). Mutat. Res., 346, 49-56.
37. Alm, P., Berntsson, S. and Oredsson, S.M. (1999) Topoisomerase II is non-functional in polyamine-depleted cells. J. Cell. Biochem., 75, 46-55.
38. 12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content and excretion in human colon tumor cells. J. Biol. Chem., 264, 11744-11749.
39. Marverti, G., Andrews, P.A., Piccinini, G., Ghiaroni, S., Barbieri, D. and Moruzzi, M.S. (1997) Modulation of cis-diamminedichloroplatinum(II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells. Eur. J. Cancer, 33, 669-675.
40. Deng, H.B., Parekh, H.K., Chow, K.C. and Simpkins, H. (2002) Increased expression of dihydrodiol dehydrogenase induces resistance to cisplatin in human ovarian carcinoma cells. J. Biol. Chem., 277. 15035-15043.
41. 12-bis(ethyl)norspermine. J. Biol. Chem., 278, 13881-13887.
42. 1-acetyltransferase. Mol. Cancer Ther., 3, 811-822.
43. Hector, S., Hawthorn, L., Greco, W. and Pendyala, L. (2002) Gene expression profiles after oxaliplatin treatment in A2780 ovarian carcinoma cells. Proc. Am. Assoc. Cancer. Res., 43, 62.
44. Warters, R.L., Newton, G.L., Olive, G.L. and Fahey, R.C. (1999) Radioprotection of human cell nuclear DNA by polyamines: radiosensitivity of chromatin is influenced by tightly bound spermine. Radiat. Res., 151, 354-362.
45. Korhonen, V.P., Niiranen, K., Halmekyto, M., Pietila, M., Diegelman, P., Parkkinen, J., Eloanta, T., Porter, C.W., Albonen, L. and Janne, J. (2001) Spermine deficiency resulting from targeted disruption of the spermine synthase gene in embryonic stem cells leads to enhanced sensitivity to antiproliferative drugs. Mol. Pharmacol., 59, 231-238.
46. Basu, S., Feuerstein, B.G., Dennis, F.D., Lubich, W.P., Bergeron, R.J., Samejima, K. and Marton, L.J. (1989) Correlation between the effects of polyamine analogues on DNA conformation and cell growth. Cancer Res., 49, 5591-5597.
47. Basu, H.S., Sturkenboom, M.C.J.M., Feuerstein, B.G. and Marton, I.J. (1992) Effect of polyamine depletion on chromatin structure in U-87 MG 251 human brain tumor cells. Biochem. J., 282, 723-727.
48. Paliwal, J., Janumpalli, G. and Basu, H.S. (1998) The mechanism of polyamine analog-induced enhancement of cisplatin cytotoxicity in the U-251 MG, human malignant glioma cell line. Cancer Chemother. Pharmacol. 1, 398-402.
49. Yang, Z., Faustino, P.J., Andrews, P.A., Monastra,R., Rasmussen, A.A., Ellison, C.D. and Cullen, K.J. (2000) Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines. Cancer Chemother. Pharmacol., 46, 255-262.